scholarly journals Transcarotid access route: a first-choice option for nontransfemoral transcatheter aortic valve implantation

2021 ◽  
Vol 79 (1) ◽  
pp. 3-4
Author(s):  
Federico Conrotto ◽  
Francesco Bruno ◽  
Fabrizio D’Ascenzo
Keyword(s):  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Access Route ◽  
Transcatheter Aortic Valve ◽  
First Choice ◽  
Aortic Valve Implantation ◽  
Valve Implantation ◽  
Choice Option

scholarly journals Severe aortic stenosis in the young, with or without bicuspid valve: is transcatheter aortic valve implantation the first choice?

2020 ◽  
Vol 22 (Supplement_L) ◽  
pp. L1-L5
Author(s):  
Igor Belluschi ◽  
Nicola Buzzatti ◽  
Alessandro Castiglioni ◽  
Michele De Bonis ◽  
Matteo Montorfano ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Stenosis ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Transcatheter Aortic Valve Implantation ◽  
Surgical Risk ◽  
Transcatheter Aortic Valve ◽  
First Choice ◽  
Aortic Valve Implantation ◽  
Valve Implantation

Abstract During the last decade, transcatheter aortic valve implantation (TAVI) has represented a valid alternative to surgical aortic valve replacement in patients with aortic stenosis and elevated surgical risk. Recent randomized clinical trials reported excellent results also for patients at low surgical risk, but in clinical practice, the mean age of the patients treated remain over 75 years, and the presence of a bicuspid aortic valve still represents an important exclusion criteria. Today, aortic valve replacement with a mechanical prosthesis remains the treatment of choice for young adults with aortic stenosis, although the desire to avoid oral anticoagulants drives more patients younger than 65 years of age towards biological prostheses. Furthermore, despite the follow-up of patients after TAVI is still limited to a few years, the opportunity of a second percutaneous treatment (TAVI-in-TAVI), extends the scope of percutaneous strategy. In the next few years, TAVI has to face many challenges to become a valid alternative to surgery in the younger patients as well.

Do Outcomes from Transcatheter Aortic Valve Implantation Vary According to Access Route and Valve Type? The UK TAVI Registry

2013 ◽  
Vol 27 (1) ◽  
pp. 86-95 ◽  
Author(s):  
DANIEL J. BLACKMAN ◽  
PAUL D. BAXTER ◽  
CHRIS P. GALE ◽  
NEIL E. MOAT ◽  
PHILIP A. MACCARTHY ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Access Route ◽  
Transcatheter Aortic Valve ◽  
Aortic Valve Implantation ◽  
The Uk ◽  
Valve Implantation

Transcatheter aortic valve implantation: the transfemoral access route is the default access

2013 ◽  
Vol 9 (S) ◽  
pp. S14-S18 ◽  
Author(s):  
Stefan Stortecky ◽  
Crochan J. O’Sullivan ◽  
Lutz Buellesfeld ◽  
Stephan Windecker ◽  
Peter Wenaweser
Keyword(s):  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Access Route ◽  
Transcatheter Aortic Valve ◽  
Aortic Valve Implantation ◽  
Valve Implantation

Access routes and the transcatheter aortic valve implantation procedure

2018 ◽  
pp. 583-588
Author(s):  
Corrado Tamburino ◽  
Claudia Ina Tamburino ◽  
Sebastiano Immè
Keyword(s):  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Access Route ◽  
Access Site ◽  
Transcatheter Aortic Valve ◽  
Alternative Approach ◽  
Edwards Sapien ◽  
Aortic Valve Implantation ◽  
Valve Implantation ◽  
Implantation Procedure

When performing transcatheter aortic valve implantation (TAVI), the access route of choice is transfemoral (TF) access since it is less invasive compared to other approaches and it is feasible in the majority of patients undergoing this procedure. Although new devices with smaller sheath sizes are available for TF-TAVI, a minority of patients still do not represent good candidates for this access route and, because of unfavourable iliofemoral arteries, need an alternative approach. Among the access site options are the transapical, direct aortic, transaxillary, or subclavian and, less frequently, transcarotid approaches. Moreover, when TF access is not feasible, the most common approaches are the transapical for the balloon-expandable Edwards SAPIEN XT valve, the subclavian for the Medtronic self-expandable CoreValve, and the transaortic for both prostheses. This chapter provides a detailed overview of all the access sites available for TAVI.

Sign in / Sign up

Export Citation Format

Share Document